May 7 |
Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
|
May 6 |
Rigel Pharmaceuticals Q1 2024 Earnings Preview
|
May 2 |
ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
Apr 30 |
Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
|
Apr 30 |
Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update
|
Apr 29 |
Rigel Pharmaceuticals: No Respect With Little Justification, Worth Considering A Buy
|
Apr 12 |
Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
|
Apr 10 |
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
|